Chung-kue Hsu - Publications

Affiliations: 
University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee SY, Tung HH, Peng LN, Chen LK, Hsu CI, Huang YL. Resilience among older cardiovascular disease patients with probable sarcopenia. Archives of Gerontology and Geriatrics. 86: 103939. PMID 31525556 DOI: 10.1016/j.archger.2019.103939  0.6
2019 Wang LJ, Li SC, Kuo HC, Chou WJ, Lee MJ, Chou MC, Tseng HH, Hsu CF, Lee SY, Lin WC. Gray matter volume and microRNA levels in patients with attention-deficit/hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience. PMID 31240443 DOI: 10.1007/s00406-019-01032-x  0.6
2018 Hsu CW, Lee SY, Wang LJ. Gender differences in the prevalence, comorbidities and antipsychotic prescription of early-onset schizophrenia: a nationwide population-based study in Taiwan. European Child & Adolescent Psychiatry. PMID 30382356 DOI: 10.1007/s00787-018-1242-9  0.6
2018 Wang LJ, Li SC, Lee MJ, Chou MC, Chou WJ, Lee SY, Hsu CW, Huang LH, Kuo HC. Blood-Bourne MicroRNA Biomarker Evaluation in Attention-Deficit/Hyperactivity Disorder of Han Chinese Individuals: An Exploratory Study. Frontiers in Psychiatry. 9: 227. PMID 29896131 DOI: 10.3389/fpsyt.2018.00227  0.6
2018 Hsu CW, Wang LJ, Lin PY. Efficacy of repetitive transcranial magnetic stimulation for Tourette syndrome: A systematic review and meta-analysis. Brain Stimulation. PMID 29885862 DOI: 10.1016/j.brs.2018.06.002  0.6
2017 Hsu CW, Lee SY, Wang LJ. Response to "Risperidone and sulpiride: Brands vs generics". Schizophrenia Research. PMID 28844637 DOI: 10.1016/j.schres.2017.08.031  0.6
2017 Hsu CW, Lee SY, Wang LJ. Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan. Schizophrenia Research. PMID 28629889 DOI: 10.1016/j.schres.2017.06.020  0.6
Show low-probability matches.